维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Vogel VG"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Effects of tamox- ifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial 显示文摘	Vogel VG Costantino JP Wickerham DL	2006	JAMA2006，295，23：	1
2	Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes显示文摘	Vogel VG Costantino JP Wickerham DL		0，，：	1
3	Effects of tamoxifen vs raloxifene on the risk of developing invasivebreast cancer and disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial显示文摘	Vogel VG Costantino JP Wickerham DL	2006	JAMA2006，295，23：	1
4	Elevated protein kinase C expressionin human breast tumor biopsies relative to normal breast tis-sue显示文摘	O′Brian CA Vogel VG	1989	Cancer Res1989，49，12：	1
5	Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes:the NSABP Study of Tamoxifen and Raloxifene(STAR)P-2trial显示文摘	Costantino JP Wickerham DL	2006	JAMA2006，295，23：	1
6	Urinary estrogen mctabolites in women at high risk for breast cancer显示文摘	Im A Vogel VG Abrendt G	2009	Carcinogenesis2009，30，5：	1
7	Inhibition of protein kinase C by the 12-O-tetradecanoylphorbol-13-acetate antagonist glycyrrhetic acid显示文摘	Brain CA Ward NE Vogel VG	1990	Cancer Lett1990，49，1：	1
8	Update of the Na- tional Surgical Adjuvant Breast and Bowel Project Study of Tamox- ifen and Raloxifene (STAR) P-2 Trial : Preventing breast cancer 显示文摘	Vogel VG Costantino JP Wickerham DL	2010	Cancer Prey Res ( Phila )2010，3，6：	1
9	Selective estrogen receptor modulators andaromatase inhibitors for breast cancer chemoprevention显示文摘	Vogel VG	2011	Curr Drug Targets2011，12，13：	1
10	Untersuchungen zum mechanismus der therapeutischen und toxischen wirkung des roβkastanien-saponins aescin显示文摘	Vogel VG Marek ML Dertner R	1970	Arznein-Forsch1970，20，5：	1
11	Management of the high-risk patient显示文摘	Vogel VG	2003	Surg Clin N Am2003，83，：	1
12	Update of the National Surgical Adjvant Breast and Bowel Project Study of Tamoxifen and Raloxifene(STAR)P-2 Trial:Preventing Breast Cancer显示文摘	Vogel VG Costantino JP Wickerham DL	2010	Cancer Prev Res(Phila)2010，3，6：	1
13	Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes:the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial显示文摘	Vogel VG Costantino JP Wickerham DL Cronin WM Cecchini RS Atkins JN		0，，：	1
14	Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes:the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial 显示文摘	Vogel VG Costantino JP Wickerham DL	2006	JAMA2006，295，23：	1
15	Effects of tamoxifen vs raloxifene on the risk of developing in vasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR)P-2 trial显示文摘	Vogel VG Costantino JP Wickerham DL	2006	JAMA2006，295，23：	1
16	Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer显示文摘	Vogel VG Costantino JP Wickerham DL	2010	Cancer Prey B es (Phila)2010，3，6：	1
17	Update of the National Surgical Adjuvant Breast and Bowel Pro- ject Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer 显示文摘	Vogel VG Costantino JP Wickerham DL	2010	Cancer Prev Res ( Phila)2010，3，6：	1
18	t,tlects oi tamoxlmn vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP study of Tamoxifen and Raloxifene ( STAR ) P-2 trial 显示文摘	Vogel VG Costantino JP Wickerham DL et at	2006	JAMA2006，295，23：	1
19	Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene ( STAR ) P-2 Trial: Preventing breast cancer 显示文摘	Vogel VG Costantino JP Wickerham DL	2010	Cancer Prey Res (Phila)2010，3，6：	1
20	Breast cancer risk management显示文摘	Reeder JG Vogel VG	2007	Clin Breast Cancer2007，7，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示